Novartis ordered to turn over files about 80,000 speaking events; drugmakers set lower-than-expected prices at launch; funding goes to R&D of antibiotics
Glaxo onboards promotional doctors
March 17, 2014
5:30 pm
The drugmaker revealed part 2 of its plan not to pay doctors to speak on GSK’s behalf: it will make them employees.
Industry mutes doctors
March 4, 2014
6:55 pm
ProPublica says drugmakers have slashed speakers’ budgets.
GSK axes speaker fees
December 17, 2013
7:20 pm
The company will still fund clinical research.
Good day, Sunshine: Tools help docs track payments
With a new era of transparency for doctors and life science manufacturers kicking off today, here’s how some organizations are keeping physicians informed.
Industry pushing for further clarity on Sunshine Act
With a clear buffet exemption in-hand, the agency’s position with respect to CME meals seems pretty clear. Industry is pushing for more clarity around the treatment of accrediting bodies.
Navidea deploying MSLs in launch of new diagnostic agent
Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.
Sales slipped 9% during the quarter, compared to the same period last year, but analysts zeroed in on if and when the company will split and how arthritis pill Xeljanz will tackle Europe.
The Swiss drug maker is defending itself against two civil fraud lawsuits filed within a week of each other.
Business briefs: Reps mum on adverse events; FCC’s new mHealth director; med schools tighten speaking limits
April 11, 2013
6:05 pm
A study finds sales reps find time to talk benefits, but not risks, even when touting black-box drugs; FCC has named its new mHealth director; pharma scaled back its food budgets last year; and AMSA says 18 med schools now ban faculty from speakers bureau participation
